Detailed View
VOR - Vor Biopharma Inc.
Latest filing: 2026-06-30 | Reporting: gaap
Market Cap
1,377,889,920
Adj EBIT (TTM)
-147,080,000
Enterprise Value
911,760,920
Last Price
23.29
Earnings Yield
-16.13%
Return on Capital
-32.24%
Capital
456,239,000
1Y Price Chart
Last Price: -
1Y Change: -
Company Summary
Loading summary...
| endDate | formType | fiscalYear | Revenue | OperatingIncomeLoss |
|---|---|---|---|---|
| 2026-06-30 | 10-Q | 2026 | 0 | -47,853,000 |
| 2026-03-31 | 10-Q | 2026 | 0 | -35,160,000 |
| 2025-12-31 | 10-K (Q4 derived) | 2025 | 0 | -35,960,000 |
| 2025-09-30 | 10-Q | 2025 | 0 | -28,107,000 |
| 2025-06-30 | 10-Q | 2025 | 0 | -274,284,000 |
| 2025-03-31 | 10-Q | 2025 | 0 | -33,291,000 |
| 2024-12-31 | 10-K (Q4 derived) | 2024 | 0 | -31,311,000 |
| 2024-09-30 | 10-Q | 2024 | 0 | -28,513,000 |
Notice something wrong?
Submit a quick report with a snapshot of the values you are seeing.